Archive for June, 2012

Osiris Therapeutics: An Old Stem Cell Biotech Coming Of Age

Osiris Therapeutics (OSIR) was founded way back in 1992, around the same time as Geron (GERN). Unlike its more famous competitor, Osiris has stayed in the stem cell game. In May this year Osiris made history by having the world’s first approved stem cell …

Osiris Bolsters its Stem Cell Intellectual Property Estate

Osiris Therapeutics, Inc. , announced today the expansion of its intellectual property protection around Prochymal® . The United States Patent and Trademark Office recently granted Osiris two patents that cover multiple mechanisms of action related to cardiac tissue repair.

UMass Med stem cell bank, age 4, to be closed

BOSTON – The University of Massachusetts Medical School and the Massachusetts Life Sciences Center have agreed to phase out operation of the embryonic stem cell bank in Shrewsbury, saying the facility, which is 4 years old, has largely outlived its usefulness.

Transplant Of Stem Cells May Beat Back Type 1 Diabetes

University of British Columbia scientists, in collaboration with an industry partner, have successfully reversed diabetes in mice using stem cells, paving the way for a breakthrough treatment for a disease that affects nearly one in four Canadians…

New Cancer Stem Cell Mechanism Identified

Scientists at Queen Mary, University of London have uncovered a link between two genes which shows how stem cells could develop into cancer. The research, published in the online journal PLoS ONE, found a novel mechanism which could be the catalyst for stem cells changing into a tumour…

Patient-Derived Stem Cells Successfully Transplant Into Mice With Muscular Dystrophy

Stem cells from patients with a rare form of muscular dystrophy have been successfully transplanted into mice affected by the same form of dystrophy, according to a new study published in Science Translational Medicine…

Medistem Receives Notice of Patent Allowance Covering Fat Stem Cell Therapy of Autoimmune Diseases

Medistem Inc. (PINKSHEETS: MEDS) announced today notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent covering the use of fat stem cells, and cells associated with fat stem cells for treatment of diseases related to a …

Scientists Correct Huntington’s Mutation in Induced Pluripotent Stem Cells

Newswise — Researchers at the Buck Institute have corrected the genetic mutation responsible for Huntington’s Disease (HD) using a human induced pluripotent stem cell (iPSC) that came from a patient suffering from the incurable, inherited …

Human model of Huntington’s disease created from skin’s stem cells

An international consortium of Huntington’s disease experts, including several from the Sue and Bill Gross Stem Cell Research Center at UC Irvine, has generated a human model of the deadly inherited disorder directly from the skin cells of affected patients.

Temple awarded $3 million in stem cell grants

EAST GREENBUSH — Sally Temple, co-founder and scientific director of the Neural Stem Cell Institute is the recipient of the Senior Scholar in Aging Award from the Ellison Medical Foundation in Bethesda, Md. The Ellison award is $1 million over a four …